When the FDA approved a new pancreatic cancer drug called Rasonque, researchers celebrated. But some patients hoping for ...

Cancer patients in Vermont and New York will soon have access to a new kind of treatment. The medication was just approved for pancreatic cancer patients, and thanks to a clinical trial, some people ...

New trial results indicate that the targeted cancer drug Daraxonrasib might also be beneficial for some patients with lung ...

Rasonque may help people with advanced pancreatic cancer live longer while offering a new treatment option in addition to ...

For decades, a diagnosis of metastatic pancreatic cancer left patients and physicians facing the same harsh reality: limited ...

A breakthrough drug recently approved to treat advanced pancreatic cancer may show promise against a specific type of lung ...

Pancreatic cancer remains one of the most aggressive malignancies, with a particularly poor prognosis even when diagnosed at ...

The Food and Drug Administration approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand ...

It took six months of doctors probing and repeatedly scanning her abdomen to find the cause of Vicky Stinson's jaundice. By the time a doctor uttered the words "pancreatic cancer," Stinson's disease ...

Cryptic peptides, which are expressed in pancreatic cancer cells, could be promising targets for T-cell therapies that attack pancreatic tumors, according to a new study. Researchers from MIT and Dana ...

Rasonque, an FDA-approved drug to treat advanced pancreatic cancer, was found in a new study to also show promise against the ...